5Connolly SJ. Preventing stoke in patients with atrial fibrillation : current treat- ments and newconcepts [ J ]. Am Heart J,2003, 145 (3) : 418-423.
6European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Carom A J, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) [J]. Eur Heart J,2010,31:2369-2429.
7Kopecky SL,Grersh BJ,MeGoon MD,et al. The natural history of lone atrial fi- brillation [ J ]. N Engl J Med, 1987,317:669-674.
8No authors listed. Adjusted-dose warfarin versus low-intensity, frxed-dose warfa- rin plus aspirin for high-risk patients with atrial fibrillation:Stroke Prevention in Atrial Fibrillation III randomised clinical trial [ J ]. Lancet, 1996,348:633-638.
9Stafford RS,Singer DE. Recent national patterns of warfarin use in atrial fibrilla- tion [ J 1. Circulation, 1998,97 : 1231-1233.
10Blackshear JL, Oden JA. Appendage obliteration to reduce stroke in cardiac sur- gical patients with atrial fibrillation [ J ]. Ann Thorac Surg, 1996,61:755 -759.